These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33887731)

  • 1. Diagnostic Pitfalls Related to Morular Metaplasia in Endometrioid Carcinoma: An Underestimated Issue.
    Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Zullo F; Insabato L
    Pathobiology; 2021; 88(3):261-266. PubMed ID: 33887731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2.
    Houghton O; Connolly LE; McCluggage WG
    Histopathology; 2008 Aug; 53(2):156-65. PubMed ID: 18752499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between morular metaplasia and squamous differentiation in endometrial carcinoma.
    Travaglino A; Raffone A; Gencarelli A; Raimondo D; Moretta P; Pignatiello S; Granata M; Seracchioli R; Zullo F; Insabato L
    Pathol Res Pract; 2021 Jan; 217():153307. PubMed ID: 33316539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia.
    Chiarelli S; Buriticá C; Litta P; Ciani S; Guarch R; Nogales FF
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4251-6. PubMed ID: 16857799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
    Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedifferentiated carcinoma of the ovary. A case report.
    Němejcová K; Rosmusová J; Bártů M; Matěj R; Dundr P
    Cesk Patol; 2018; 54(1):33-36. PubMed ID: 29631410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian sertoli cell tumor.
    Zhao C; Barner R; Vinh TN; McManus K; Dabbs D; Vang R
    Int J Gynecol Pathol; 2008 Oct; 27(4):507-14. PubMed ID: 18753972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.
    Hatano Y; Tamada M; Asano N; Hayasaki Y; Tomita H; Morishige KI; Hara A
    Diagn Pathol; 2019 Jan; 14(1):4. PubMed ID: 30636633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
    Ramalingam P; Masand RP; Euscher ED; Malpica A
    Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does endometrial morular metaplasia represent odontogenic differentiation?
    Travaglino A; Raffone A; Russo D; Guadagno E; Pignatiello S; Moretta P; Zullo F; Del Basso De Caro M; Insabato L; Mascolo M
    Virchows Arch; 2021 Sep; 479(3):607-616. PubMed ID: 33666744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem.
    Woodbeck R; Kelemen LE; Köbel M
    Int J Gynecol Pathol; 2019 Nov; 38(6):568-575. PubMed ID: 30480647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Young RH; Hart WR
    Am J Surg Pathol; 1998 Jul; 22(7):805-15. PubMed ID: 9669343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases.
    Mansor S; McCluggage WG
    Int J Gynecol Pathol; 2014 Sep; 33(5):470-6. PubMed ID: 25083962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
    Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.